Skip to main content
. Author manuscript; available in PMC: 2013 Jun 24.
Published in final edited form as: Am J Crit Care. 2009 Jan;18(1):42–51. doi: 10.4037/ajcc2009509

Table 2.

Characteristics of the sample (n =14)a

Patient No. Age, y Sex Intensive care unit length of stay, d Score on Acute Physiology and Chronic Health Evaluation II Sedative used Analgesic agent used
1 65 Female 4 37 Midazolam Fentanyl
2 37 Female 2 25 Propofol Fentanyl
3 69 Female 9 35 None Fentanyl
4 57 Female 3 20 Midazolam Fentanyl
5 41 Female 5 17 Midazolam/dilaudid Fentanyl/morphine
6 35 Female 0 31 Midazolam Fentanyl
7 28 Female 7 19 None Fentanyl/hydromorphone
8 22 Male 5 32 Lorazepam/midazolam Fentanyl
9 38 Female 3 23 Lorazepam/midazolam Fentanyl
10 56 Male 2 30 Lorazepam Fentanyl
11 56 Male 2 32 Lorazepam Fentanyl
12 42 Female 3 28 Propofol Fentanyl
13 60 Female 2 36 Lorazepam Fentanyl
14 19 Female 3 33 Midazolam Fentanyl
a

Patient 6 was admitted because of sepsis; all other patients were admitted because of acute respiratory failure.